Who to call at Carisma Therapeutics Inc., and when
Fundz watches for the moments Carisma Therapeutics Inc. starts buying, and tells you who to reach.
- An alert the day Carisma Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Carisma Therapeutics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Carisma Therapeutics Inc.. With Fundz connected, it knows.
Carisma Therapeutics Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
elevenbio.comLeadership shakeup: 3 executive changes at Eleven Biotherapeutics, Inc. in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Carisma Therapeutics terminated without cause its President and CEO Steven Kelly (effective November 15, 2025) and its Chief Scientific Officer Michael Klichinsky (effective October 15, 2025) as part of an orderly wind-down of remaining operations. The company is pursuing the sale or monetization of its remaining assets, and the departures signal a transition toward closure.
Key Takeaways
Both the CEO and CSO are being terminated without cause, leaving the company's senior scientific and executive leadership largely vacated during its wind-down.
Kelly's separation package includes a 12-month base salary lump sum, a pro-rated 2025 target bonus at 100%, and monthly payments of $3,757 for up to 12 months or until he obtains health coverage elsew
3 more takeaways
Related Filings (2)
2 more filings from Carisma Therapeutics Inc. in the last 90 days
Filing Overview
What This Means
Carisma Therapeutics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.